Literature DB >> 2568561

Rapamycin for immunosuppression in organ allografting.

R Y Calne, D S Collier, S Lim, S G Pollard, A Samaan, D J White, S Thiru.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2568561     DOI： 10.1016/s0140-6736(89)90417-0

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  68 in total

Review 1.  Advances in the development of immunosuppressive agents in organ transplantation.

Authors:  T Ochiai; K Isono
Journal:  Surg Today       Date:  1997       Impact factor: 2.549

Review 2.  Immunomodulators. Future prospects.

Authors:  B C Takx-Köhlen
Journal:  Pharm Weekbl Sci       Date:  1992-08-21

3.  Synergistic activity of rapamycin and dexamethasone in vitro and in vivo in acute lymphoblastic leukemia via cell-cycle arrest and apoptosis.

Authors:  Chong Zhang; Yong-Ku Ryu; Taylor Z Chen; Connor P Hall; Daniel R Webster; Min H Kang
Journal:  Leuk Res       Date:  2011-12-03       Impact factor: 3.156

4.  Rapamycin improves lymphoproliferative disease in murine autoimmune lymphoproliferative syndrome (ALPS).

Authors:  David T Teachey; Dana A Obzut; Kelly Axsom; John K Choi; Kelly C Goldsmith; Junior Hall; Jessica Hulitt; Catherine S Manno; John M Maris; Nicholas Rhodin; Kathleen E Sullivan; Valerie I Brown; Stephan A Grupp
Journal:  Blood       Date:  2006-06-06       Impact factor: 22.113

5.  Extracellular Ca2+ uptake by T cells might help to make a diagnosis of acute rejection.

Authors:  Kenjiro Akiyoshi; Shigeki Hikida; Hiroyoshi Inoue; Kimio Asagiri; Yoshiaki Tanaka; Minoru Yagi
Journal:  Pediatr Surg Int       Date:  2006-12-12       Impact factor: 1.827

Review 6.  mTOR activation is a biomarker and a central pathway to autoimmune disorders, cancer, obesity, and aging.

Authors:  Andras Perl
Journal:  Ann N Y Acad Sci       Date:  2015-04-23       Impact factor: 5.691

Review 7.  Surgical biology for the clinician: vascular effects of immunosuppression.

Authors:  Elissa Tepperman; Danny Ramzy; Jessica Prodger; Rohit Sheshgiri; Mitesh Badiwala; Heather Ross; Vivek Raoa
Journal:  Can J Surg       Date:  2010-02       Impact factor: 2.089

8.  The biosynthetic gene cluster for the polyketide immunosuppressant rapamycin.

Authors:  T Schwecke; J F Aparicio; I Molnár; A König; L E Khaw; S F Haydock; M Oliynyk; P Caffrey; J Cortés; J B Lester
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

9.  Development of a high-throughput cell-based reporter assay to identify stabilizers of tumor suppressor Pdcd4.

Authors:  Johanna S Blees; Tobias Schmid; Cheryl L Thomas; Alyson R Baker; Lauren Benson; Jason R Evans; Ekaterina I Goncharova; Nancy H Colburn; James B McMahon; Curtis J Henrich
Journal:  J Biomol Screen       Date:  2009-11-09

10.  Rapamycin is active against B-precursor leukemia in vitro and in vivo, an effect that is modulated by IL-7-mediated signaling.

Authors:  Valerie I Brown; Junjie Fang; Keith Alcorn; Rosalind Barr; Jenny M Kim; Robert Wasserman; Stephan A Grupp
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-01       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.